Third European Patent for Biomarker Submitted!

Tuesday, 01 January 2013 More News

After submitting european patents for lysosomal storage deseases in 2011 (Gaucher) and 2012 (NPC) in December last year we submitted another patent for a marker for MLD!

All three markers have remarkably high sensitivity as well as specificity.
pharm-analyt is continuously investigating in biomarkers, predominantly Small Molecules in plasma.

<< back

Did you know:

Throughout the

40 years

of pharm-analyt’s existence it
was always equipped with
state-of-the-art instrumentation.
We work, where the

Austrian Emperors

went on vacation.

(Historical town of Baden)
“Edelweiss”

is not the Austrian anthem.
It is our national flower.
Rumors say:

…For a remarkable bottle of

Chardonnay,

our founder Hermann Mascher would conduct the analysis of a large clinical study for free. :-)
Our first look might be

invaluable

and it’s for free!
Every day

we are learning something
about bioanalysis.
Rumors say:

…Of all of our equipment, the
highest throughput is with our

espresso machine?!
Our most sensitive method has an LLOQ of

0.00000000000005

g/mL plasma.

= 50 femtogram/mL
or 50 x 10^-15 g/mL
or 200 g sugar in lake Chiemsee!
Why our founder’s

hairstyle

sometimes reminds of a well known nuclear physicist? Tell us if you know!
pharm-analyt has been
GLP certified for almost

30 years.
We are

giving away

a lot of our know-how in Hermann’s book “HPLC Methods for Clinical Pharmaceutical Analysis”.

(See R&D)
You will get the clinical PK profile of

250

common drugs from us for free.

Contact us.
"Never give in,
never, never
never, never, in nothing great or small."
(Sir Winston Churchill)
In a number of cases chemical

derivatization

might be the key to
success in bioanalysis.
They say

it’s not feasible?

Give us a try.
We are

locals

in the area of trace analysis.
Inpassible…? Imposibol…? Unpossibal…?

Sorry, we’re just not
familiar with this word.
pharm-analyt has developed bioanalytical assays for more than

400 compounds.
pharm-analyt has discovered biomarkers that will save

the lives of thousands of children

suffering from various rare diseases.
pharm-analyt is

fully family-owned.
pharm-analyt was founded

long before

mass spec was widespread.
50 %

of the analytical know-how lies
in sample preparation.
A part of our historical
premises used to be a

bakery

before we moved in.
We are

always eager
for difficult analytical challenges.
A quote from one of our collaborators concerning PEG tissue analysis: I am totally blown away by the fact that not only do you have measurable levels of PEG

but they are also dose-dependent!!

Amazing stuff!!
pharm-analyt has sold

4 European patents

on biomarkers.
pharm-analyt has won

several awards

for innovation.
pharm-analyt has over

100 publications

in peer reviewed journals.
pharm-analyt was

one of the first

CROs to switch to electronic archiving.
pharm-analyt requires as little as

50 µL

sample volume for clinical studies,
if necessary.
pharm-analyt has developed
multiple ways of

stabilizing peptides

in plasma.

›

‹

40 years

Austrian Emperors

“Edelweiss”

Chardonnay,

invaluable

Every day

espresso machine?!

0.00000000000005

hairstyle

30 years.

giving away

250

never, never

derivatization

it’s not feasible?

locals

Inpassible…? Imposibol…? Unpossibal…?

400 compounds.

the lives of thousands of children

fully family-owned.

long before

50 %

bakery

always eager

but they are also dose-dependent!!

4 European patents

several awards

100 publications

one of the first

50 µL

stabilizing peptides